Last reviewed · How we verify

NCT05662592

Evaluation of Broadband Light Treatment Protocol for Pigmented Skin Lesions - A Comparative Study

Completed NA Last updated 1 December 2023
What this trial tests

NA trial testing Broadband Light in Pigmentation in 3 participants. Completed in 6 June 2023.

Timeline
1 October 2022
Primary endpoint
30 May 2023
6 June 2023

Quick facts

Lead sponsorSciton
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment3
Start date1 October 2022
Primary completion30 May 2023
Estimated completion6 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Sciton

Who can join

18 and older, any sex, with Pigmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of Broadband Light Treatment Protocols for Pigmented Skin Lesions - A comparative study

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Broadband Light

Trials testing the same drug.

Other recruiting trials for Pigmentation

Currently open trials in the same condition.

Other Sciton trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05662592.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing